<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <cboCostEstimates />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <notes />
    <committeeReports />
    <titles>
      <item>
        <chamberCode />
        <chamberName />
        <title>FDA Accountability for Public Safety Act</title>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <title>A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <title>FDA Accountability for Public Safety Act</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
      </item>
    </titles>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2015-04-15</actionDate>
          <text><![CDATA[<p><b>FDA Accountability for Public Safety Act</b></p> <p>This bill requires the Commissioner of Food and Drugs to ensure that an advisory committee of the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) evaluates each new drug application for an opioid (a drug with effects similar to opium, such as morphine) and issues a recommendation regarding approval of the drug. If the decision to approve the drug is inconsistent with the committee's recommendation, the Commissioner must make the final decision on approval.</p> If the committee recommends a drug not be approved but the Commissioner decides to approve the drug, the Commissioner must: (1) submit a report to Congress that includes the evidence regarding patient safety that supports the Commissioner's decision and a disclosure of any potential conflicts of interest of FDA officials involved in the decision to approve the drug; and (2) testify before Congress regarding the decision, upon request. Such a drug cannot be sold until the Commissioner has submitted the required report.]]></text>
          <lastSummaryUpdateDate>2015-09-03T14:00:40Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <name>Introduced in Senate</name>
          <updateDate>2015-04-15T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <createDate>2015-04-16T09:11:20Z</createDate>
    <recordedVotes />
    <billNumber>954</billNumber>
    <introducedDate>2015-04-15</introducedDate>
    <relatedBills />
    <updateDate>2016-11-02T23:25:27Z</updateDate>
    <committees>
      <billCommittees>
        <item>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-04-15T19:35:56Z</date>
            </item>
          </activities>
          <type>Standing</type>
          <chamber>Senate</chamber>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <congress>114</congress>
    <laws />
    <title>FDA Accountability for Public Safety Act</title>
    <calendarNumbers />
    <sponsors>
      <item>
        <identifiers>
          <lisID>1983</lisID>
          <gpoId>8256</gpoId>
          <bioguideId>M001183</bioguideId>
        </identifiers>
        <byRequestType />
        <fullName>Sen. Manchin, Joe, III [D-WV]</fullName>
        <firstName>Joe</firstName>
        <state>WV</state>
        <bioguideId>M001183</bioguideId>
        <middleName />
        <party>D</party>
        <lastName>Manchin</lastName>
      </item>
    </sponsors>
    <actions>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <item>
        <actionDate>2015-04-15</actionDate>
        <committee>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <text>Introduced in Senate</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <links />
        <actionCode>10000</actionCode>
        <actionDate>2015-04-15</actionDate>
      </item>
    </actions>
    <amendments />
    <originChamber>Senate</originChamber>
    <latestAction>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <actionDate>2015-04-15</actionDate>
      <links />
    </latestAction>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Federal officials</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Government ethics and transparency, public corruption</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <cosponsors>
      <item>
        <firstName>David</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Vitter, David [R-LA]</fullName>
        <identifiers>
          <gpoId>8267</gpoId>
          <lisID>1609</lisID>
          <bioguideId>V000127</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-04-15</sponsorshipDate>
        <party>R</party>
        <bioguideId>V000127</bioguideId>
        <state>LA</state>
        <lastName>Vitter</lastName>
      </item>
      <item>
        <firstName>SHELLEY</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Capito, Shelley Moore [R-WV]</fullName>
        <identifiers>
          <bioguideId>C001047</bioguideId>
          <lisID>1676</lisID>
          <gpoId>8223</gpoId>
        </identifiers>
        <middleName>MOORE</middleName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-04-15</sponsorshipDate>
        <party>R</party>
        <bioguideId>C001047</bioguideId>
        <state>WV</state>
        <lastName>CAPITO</lastName>
      </item>
      <item>
        <firstName>Timothy</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Kaine, Tim [D-VA]</fullName>
        <identifiers>
          <gpoId />
          <lisID>2176</lisID>
          <bioguideId>K000384</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-04-15</sponsorshipDate>
        <party>D</party>
        <bioguideId>K000384</bioguideId>
        <state>VA</state>
        <lastName>Kaine</lastName>
      </item>
      <item>
        <firstName>Claire</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. McCaskill, Claire [D-MO]</fullName>
        <identifiers>
          <lisID>1820</lisID>
          <bioguideId>M001170</bioguideId>
          <gpoId>8252</gpoId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-09-09</sponsorshipDate>
        <party>D</party>
        <bioguideId>M001170</bioguideId>
        <state>MO</state>
        <lastName>McCaskill</lastName>
      </item>
      <item>
        <firstName>Angus</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. King, Angus S., Jr. [I-ME]</fullName>
        <identifiers>
          <bioguideId>K000383</bioguideId>
          <gpoId />
          <lisID>2185</lisID>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-11-19</sponsorshipDate>
        <party>I</party>
        <bioguideId>K000383</bioguideId>
        <state>ME</state>
        <lastName>King</lastName>
      </item>
    </cosponsors>
    <billType>S</billType>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

